| NCT ID | NCT07214883 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Central Florida |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2025-09-03 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000 participants in total. It began in 2025-09-03 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to develop AI models to better read diagnostic mammograms for various populations and types of breast cancer, using the images that participants donate and their responses from study questionnaire to improve patient outcomes. This study also aims to provide mammography images to participants.
Eligibility Criteria
Inclusion Criteria: * Adults, ages 18 and older * Had a radiographic breast cancer imaging test, either for screening or diagnosis of breast cancer, with either positive or negative results performed in a US institution. * Have an email account with access to a reliable internet connection or smartphone * Pregnant women may choose to participate. Exclusion Criteria: * Minors , ages under 18 * Prisoners * Adults who are unable to provide consent.
Contact & Investigator
Jane Gibson, PhD
PRINCIPAL INVESTIGATOR
University of Central Florida
Frequently Asked Questions
Who can join the NCT07214883 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07214883 currently recruiting?
Yes, NCT07214883 is actively recruiting participants. Contact the research team at Amoy.Fraser@ucf.edu for enrollment information.
Where is the NCT07214883 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT07214883 clinical trial?
NCT07214883 is sponsored by University of Central Florida. The principal investigator is Jane Gibson, PhD at University of Central Florida. The trial plans to enroll 20,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.